Study guide
4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome
Certified Burn Registered Nurse CBRN
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Foundations of Burn Care
1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones
2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response
2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology
3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria
3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics
4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)
4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy
5 Chapter 5: Airway Management & Inhalation Injury Management
5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)
6 Chapter 6: Acute Multisystem Assessment & Critical Care Management
6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection
7 Chapter 7: Hypermetabolism & Nutritional Support
7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation
8 Chapter 8: Pain Management in Burn Care
8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction
9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus
9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients
10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings
10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances
11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure
11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management
12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy
12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion
13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries
13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy
14 Chapter 14: Special Burn Populations & Cutaneous Syndromes
14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries
15 Chapter 15: Rehabilitation, Scar Management & Reconstruction
15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management
16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage
16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response
4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome
Key Takeaways Explain This Topic AI
Fluid creep refers to the iatrogenic over-administration of resuscitation crystalloids significantly exceeding formula estimates, defined clinically by an Ivy Index >250 mL/kg in the first 24 hours.
Major drivers of fluid creep include titrating fluids to non-specific tachycardia or hypotension rather than urine output, high sedation and opioid requirements causing vasodilation, inhalation injury, and unchecked bolus culture.
Normal intra-abdominal pressure (IAP) is 5–7 mmHg; Intra-Abdominal Hypertension (IAH) is defined as sustained IAP ≥12 mmHg, and Abdominal Compartment Syndrome (ACS) is defined as sustained IAP >20 mmHg associated with new end-organ failure.
IAP is measured using the standardized transvesical closed bladder pressure technique, instilling 25 mL of sterile saline with the transducer zeroed at the mid-axillary line at the level of the iliac crest.
Management of IAH/ACS follows a progressive ladder: gastric decompression, sedation/neuromuscular blockade, colloid rescue (5% albumin), percutaneous drainage, and emergent decompressive laparotomy.
Last updated: August 2026
4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome
Core Knowledge: First identified by Dr. Basil A. Pruitt Jr. in 2000, "fluid creep" describes the systemic iatrogenic phenomenon wherein burn patients receive crystalloid volumes vastly exceeding historical formula predictions. While under-resuscitation leads to acute renal failure and shock, over-resuscitation generates devastating hydrostatic pressure gradients across permeable capillary beds, culminating in pulmonary edema, ocular compartment syndrome, extremity compartment syndromes, and life-threatening Abdominal Compartment Syndrome (ACS) .
1. Pathophysiology and Etiology of Fluid Creep
During the initial 24 to 48 hours post-burn, systemic endothelial junctions are disrupted. Every milliliter of crystalloid administered distributes across both intravascular and extravascular compartments; in extensive burns, approximately 70% to 80% of infused crystalloid extravasates into the interstitium . THE VICIOUS CYCLE OF FLUID CREEP
- ┌─────────────────────────────────────────────────────────────────────────────┐
- │ Inappropriate Fluid Escalation (Treating Tachycardia / Non-specific BP) │
- │ │ │
- │ ▼ │
- │ Massive Interstitial Edema & Splanchnic Visceral Swelling │
- │ │ │
- │ ▼ │
- │ Increased Intra-Abdominal Pressure (IAP ≥ 12 mmHg) │
- │ │ │
- │ ▼ │
- │ Renal Vein & Glomerular Compression ──► Oliguria / Falling UOP │
- │ │ │
- │ ▼ │
- │ Clinician Interprets Oliguria as "Hypovolemia" ──► Administers MORE Fluids! │
- └─────────────────────────────────────────────────────────────────────────────┘
- The Ivy Index Threshold
The Ivy Index establishes that receiving > 250 mL/kg of crystalloid in the first 24 hours (or >6 mL/kg/%TBSA) is the single most powerful independent predictor of developing secondary abdominal compartment syndrome, ocular ischemia, and multi-organ failure. For an 80-kg patient, this threshold is reached at 20,000 mL (20 Liters) of fluid.
Primary Etiological Drivers of Fluid Creep
Titrating to Non-Perfusion Variables: Escalating fluid infusion rates to treat isolated tachycardia (>120 bpm) or modest hypotension in patients who already have adequate hourly urine output (e.g., >0.5–1.0 mL/kg/hr).
Sedation & Opioid-Induced Vasodilation: High-dose continuous infusions of propofol, dexmedetomidine, or opioids induce systemic arterial and venous vasodilation. Clinicians frequently misinterpret sedation-induced vasodilation as burn shock hypovolemia and infuse massive crystalloid volumes.
The "Bolus Mentality": Utilizing frequent 500–1,000 mL manual crystalloid boluses in response to brief dips in hourly UOP rather than executing gentle 10% to 20% pump titrations.
Severe Concomitant Inhalation Injury: Inhalation trauma amplifies systemic inflammatory cytokine release, accelerating capillary leak and increasing fluid requirements by 30% to 50% above baseline formulas.
Unrecognized Stress-Induced Glycosuria: Osmotic diuresis masks hypovolemia or leads to over-correction.
2. Systemic End-Organ Complications of Over-Resuscitation
Organ System Pathophysiological Manifestation Clinical Presentation & Nursing Assessment
Pulmonary Non-cardiogenic pulmonary edema, loss of alveolar surfactant, ARDS Spiking peak inspiratory pressures, falling P a O 2 / F i O 2 PaO_2/FiO_2 P a O 2 / F i O 2 ratio (<200–300), copious frothy tracheal secretions, diffuse bilateral infiltrates on chest X-ray.
Abdominal Splanchnic visceral edema, bowel wall thickening, mesenteric venous congestion Intra-abdominal hypertension (IAH), tense distended abdomen, abdominal compartment syndrome (ACS), ischemic bowel, oliguria.
Ophthalmic Retrobulbar orbital edema, central retinal artery compression Orbital Compartment Syndrome (OCS), proptosis, tense globe, intraocular pressure (IOP) >30 mmHg, irreversible blindness if lateral canthotomy is delayed.
Extremities Massive soft tissue edema under unburned or burned skin Secondary extremity compartment syndrome in unburned limbs; conversion of partial-thickness burns into full-thickness necrosis.
Cardiovascular Myocardial edema, diastolic dysfunction, elevated CVP Decreased cardiac compliance, impaired ventricular filling, worsening systemic perfusion despite massive fluid positive balance.
Neurological Diffuse cerebral edema Decreased level of consciousness, agitation, elevated intracranial pressure (ICP), encephalopathy.
3. Intra-Abdominal Hypertension (IAH) & Abdominal Compartment Syndrome (ACS)
The peritoneal cavity is a semi-rigid compartment bounded by the abdominal wall, spine, pelvis, and diaphragm. Massive crystalloid infusion causes profound retroperitoneal, mesenteric, and intestinal wall edema.
WSACS Definitions and Grading Criteria
The World Society of the Abdominal Compartment Syndrome (WSACS) establishes standard definitions for critically ill patients:
Normal Intra-Abdominal Pressure (IAP): 5 to 7 mmHg in healthy, non-obese supine adults (up to 9–14 mmHg in critically ill burn/trauma patients).
Intra-Abdominal Hypertension (IAH): Sustained or repeated pathological elevation of IAP ≥ 12 mmHg .
Abdominal Compartment Syndrome (ACS): Sustained IAP > 20 mmHg (with or without an Abdominal Perfusion Pressure [APP = MAP - IAP] < 60 mmHg) associated with new-onset organ dysfunction or failure . WSACS IAH CLASSIFICATION GRADES
- ┌──────────────────────┬──────────────────────────────────────────────────────┐
- │ Grade I IAH │ IAP 12 to 15 mmHg │
- ├──────────────────────┼──────────────────────────────────────────────────────┤
- │ Grade II IAH │ IAP 16 to 20 mmHg │
- ├──────────────────────┼──────────────────────────────────────────────────────┤
- │ Grade III IAH │ IAP 21 to 25 mmHg │
- ├──────────────────────┼──────────────────────────────────────────────────────┤
- │ Grade IV IAH │ IAP > 25 mmHg │
- ├──────────────────────┼──────────────────────────────────────────────────────┤
- │ ACS │ IAP > 20 mmHg + NEW-ONSET END-ORGAN DYSFUNCTION │
- └──────────────────────┴──────────────────────────────────────────────────────┘
- The Clinical Triad of Abdominal Compartment Syndrome
When IAP exceeds 20 mmHg, physical pressure produces a lethal systemic triad:
Oliguria / Anuria Refractory to Fluids: Compression of renal veins and renal parenchyma reduces renal perfusion pressure and glomerular filtration rate.
Respiratory Failure with Spiking Peak Airway Pressures: Cephalad (upward) displacement of the diaphragm compresses the thoracic cavity, collapsing lung bases, driving peak inspiratory pressures >40 to 45 cm H2O , and precipitating severe hypercapnic/hypoxemic respiratory failure.
Hemodynamic Collapse / Refractory Hypotension: Compression of the inferior vena cava and portal vein drastically impedes venous return to the right heart, precipitating a catastrophic drop in cardiac preload, stroke volume, and cardiac output.
4. Measurement Technique: Transvesical Closed Bladder Pressure
Transvesical bladder pressure monitoring is the gold standard, non-invasive method for measuring IAP. The urinary bladder wall acts as a passive, compliant diaphragm reflecting intra-peritoneal pressure. BLADDER PRESSURE TRANSDUCTION PROTOCOL
- ┌───┬─────────────────────────────────────────────────────────────────────────┐
- │ 1 │ Position the patient completely FLAT and SUPINE (0° head of bed). │
- │ │ *Elevating the head of bed falsely increases IAP by 4-9 mmHg.* │
- ├───┼─────────────────────────────────────────────────────────────────────────┤
- │ 2 │ Ensure the bladder is fully drained, then clamp the drainage tubing. │
- ├───┼─────────────────────────────────────────────────────────────────────────┤
- │ 3 │ Instill EXACTLY 25 mL of sterile saline into the Foley via port/closed │
- │ │ transducer manifold. (Volumes >25 mL falsely elevate bladder pressure). │
- ├───┼─────────────────────────────────────────────────────────────────────────┤
- │ 4 │ Zero the pressure transducer at the MID-AXILLARY LINE at the level of │
- │ │ the ILIAC CREST (phlebostatic axis equivalent for pelvis). │
- ├───┼─────────────────────────────────────────────────────────────────────────┤
- │ 5 │ Measure pressure in mmHg at END-EXPIRATION in the absence of active │
- │ │ abdominal muscle contractions or shivering. │
- └───┴─────────────────────────────────────────────────────────────────────────┘
- 5. Stepwise Management Ladder for IAH and ACS
Management progresses rapidly from conservative medical decompression to emergent surgical intervention based on IAP trends and organ failure: STEPWISE MANAGEMENT LADDER FOR IAH & ACS
- │
- ▼
- ┌─────────────────────────────────────────────────────────────────────────────┐
- │ STEP 1: Evacuate Intraluminal Gastrointestinal Contents │
- │ • Insert NG/OG tube to low continuous suction; aspirate gastric residuals │
- │ • Administer prokinetic agents (metoclopramide, erythromycin) │
- │ • Administer rectal tube / gentle enemas for colonic decompression │
- └────────────────────────────────────┬────────────────────────────────────────┘
- │ (If IAP Remains ≥12-15 mmHg)
- ▼
- ┌─────────────────────────────────────────────────────────────────────────────┐
- │ STEP 2: Optimize Fluid Resuscitation & Initiate Colloid Rescue │
- │ • Immediately halt crystalloid over-administration (down-titrate LR) │
- │ • Initiate Colloid Rescue: 5% Albumin (0.5 to 1.0 mL/kg/%TBSA/24h) or FFP │
- │ to draw interstitial fluid into intravascular space and reduce crystalloid│
- │ • Avoid fluid boluses; consider hypertonic saline solutions │
- └────────────────────────────────────┬────────────────────────────────────────┘
- │ (If IAP Climbs to 16-20 mmHg)
- ▼
- ┌─────────────────────────────────────────────────────────────────────────────┐
- │ STEP 3: Optimize Abdominal Wall Compliance │
- │ • Deepen sedation and provide adequate opioid analgesia │
- │ • Trial of temporary neuromuscular blockade (paralytic infusion) │
- │ • Perform escharotomy of full-thickness abdominal wall eschar if present │
- └────────────────────────────────────┬────────────────────────────────────────┘
- │ (If IAP >20 mmHg or Peritoneal Fluid Present)
- ▼
- ┌─────────────────────────────────────────────────────────────────────────────┐
- │ STEP 4: Percutaneous Catheter Decompression (Paracentesis) │
- │ • Ultrasound-guided placement of percutaneous peritoneal catheter (pigtail) │
- │ • Drain free ascites/peritoneal fluid (can immediately reduce IAP by 5-10) │
- └────────────────────────────────────┬────────────────────────────────────────┘
- │ (If Refractory ACS: IAP >20 mmHg + Organ Failure)
- ▼
- ┌─────────────────────────────────────────────────────────────────────────────┐
- │ STEP 5: Emergent Surgical Decompressive Laparotomy │
- │ • Bedside or operating room midline surgical laparotomy (open abdomen) │
- │ • Immediate release of intra-abdominal pressure │
- │ • Temporary abdominal closure (Bogota bag or negative-pressure VAC dressing)│
- └─────────────────────────────────────────────────────────────────────────────┘
Caution
If medical management fails and the patient exhibits full ACS (IAP >20 mmHg with refractory oliguria, peak pressures >45 cm H2O, and hypotension), surgical decompressive laparotomy is life-saving and must not be delayed. Failure to decompress results in 100% mortality from visceral ischemia and cardiovascular collapse.